In vitro metabolism of the analgesic agent, RWJ-236264, in mouse hepatic S9 fraction

被引：0
|
作者：
Wu, WN [1 ]
McKown, LA [1 ]
Carson, JR [1 ]
机构：
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA 19477 USA
来源：
DRUG METABOLISM REVIEWS | 2002年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
161
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [31] Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism
    Wu, Wu-Nan
    McKown, Linda A.
    Reitz, Allen B.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2006, 31 (04) : 277 - 283
  • [32] Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism
    Wu-Nan Wu
    Linda A. Mckown
    Allen B. Reitz
    European Journal of Drug Metabolism and Pharmacokinetics, 2006, 31 : 277 - 283
  • [33] STUDIES OF THE METABOLIZING EFFECT OF THE S9 LIVER FRACTION, HEPATIC MICROSOMES AND MICROSOMAL SUPERNATANT IN THE AMES TEST
    ARNI, P
    LUTH, A
    DEPARADE, E
    MULLER, D
    MUTATION RESEARCH, 1980, 74 (02): : 154 - 154
  • [34] Metabolomic analysis for the metabolites of estrogenic pesticides with liver S9 fractions as in vitro hepatic model
    Auh, Joong-Hyuck
    Kim, Gyoung-Deuck
    Lee, Hee-Seok
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [35] Bioavailability of hydrophobic organic chemicals on an in vitro metabolic transformation using rat liver S9 fraction
    Kwon, Jung-Hwan
    Lee, Hyun-Jeoung
    Escher, Beate, I
    TOXICOLOGY IN VITRO, 2020, 66
  • [36] Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds
    Jyrkas, Juha
    Tolonen, Ari
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 196
  • [37] In vitro metabolism of mifepristone (RU-486) in rat, monkey and human hepatic S9 fractions:: identification of three new mifepristone metabolites
    Wu, WN
    McKown, LA
    Moyer, MD
    Johannsen, TB
    Takacs, AR
    XENOBIOTICA, 1999, 29 (11) : 1089 - 1100
  • [38] In Vitro Metabolic Transformation of Pharmaceuticals by Hepatic S9 Fractions from Common Carp (Cyprinus carpio)
    Burkina, Viktoriia
    Sakalli, Sidika
    Pham Thai Giang
    Grabicova, Katerina
    Stanova, Andrea Vojs
    Zamaratskaia, Galia
    Zlabek, Vladimir
    MOLECULES, 2020, 25 (11):
  • [39] Comparison of trout hepatocytes and liver S9 fractions as in vitro models for predicting hepatic clearance in fish
    Fay, Kellie A.
    Fitzsimmons, Patrick N.
    Hoffman, Alex D.
    Nichols, John W.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2017, 36 (02) : 463 - 471
  • [40] EFFECT OF REPEATED ETHER ANESTHESIAS ON THE MONO-OXYGENASE SYSTEM OF MOUSE-LIVER S9 FRACTION
    BAUER, C
    BRONZETTI, G
    CORSI, C
    DEL CARRATORE, R
    NIERI, R
    PAOLINI, M
    MUTATION RESEARCH, 1983, 119 (01): : 15 - 19
12345